Healthy adult
Conditions
Interventions
Ingestion of supplement containing anserine for 12 weeks
Ingestion of placebo without anserine for 12 weeks
Sponsors
KSO Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Healthy males and females aged 20 to 64 years old 2.Individuals whose serum uric acid are from 5.5 mg/dL to 7.0 mg/dL 3.Individuals who can make self-judgment and are voluntarily giving written informed consent
Exclusion criteria
Exclusion criteria: 1.Individuals who use medications affecting uric acid metabolism 2.Individuals who cannot stop using supplements and/or functional foods affecting serum uric acid 3.Individuals who contract hyperuricemia needing treatment 4.Individuals who have a history of gout or are under treatment of gout 5. Individuals who have drinking habit more than 60 g in terms of pure alcohol a day for more than 5 days a week 6. Individuals who cannot stop drinking from 2 days before visit 7. Individuals who have a history of food allergy 8. Individuals who are under treatment or have a history of disease e.g., serious hyperlipidemia, diabetes, kidney disease, liver disease, or heart disease., thyroid disease, adrenal disease, or metabolic diseases 9. Individuals who use a medicine 10. Individuals who have chronic disease and regularly use medicines 11. Individuals who have a history of gastroenterological disease or operation on digestive organ 12.Individuals who are judged as unsuitable for the study because of the result of blood chemistry and hematology test at screening test 13.Individuals who have donated blood components and/or blood a volume of 200 mL and over within one month prior to the current study 14. Individuals who have under treatment or a history of drug addiction and/or alcoholism 15.Individuals who are planning to participate or already participating in other clinical studies 16.Individuals who are judged as unsuitable for the study by the investigator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum uric acid at 4-week, 8-week, 12-week consumption | — |
Secondary
| Measure | Time frame |
|---|---|
| Uric acid excretion in the urine, 8-OHdG in the urine, questionnaire of daily habit, SF-8 and visual analogue scale to evaluate fatigue severity | — |
Countries
Japan
Contacts
Public ContactEiji Yoshikawa
KSO Corporation Sales department
Outcome results
None listed